Abstract
Cite this article as:
Satoh H, Miyazaki K, Sato Y, Hizawa N. Response to afatinib in a common EGFR-mutated lung adenocarcinoma with a very rare combination of compound mutations. Turk Thorac J. 2022;23(5):364-365.
Keywords:
Response to Afatinib in a Common EGFR-Mutated Lung Adenocarcinoma with a Very Rare Combination of Compound Mutations
Turk Thorac J 2022;23(5):364-365
1. Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba
2. Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital
3. DNA Chip Research Inc. (Tokyo, Japan)
4. Division of Respiratory Medicine, Faculty of Clinical Medicine, University of Tsukuba
No information available.
No information available
Accepted Date: 11.08.2022
Online Date: 01.09.2022
Publish Date: 11.08.2022
2024 ©️ Galenos Publishing House